How far we have come with eosinophilis in COPD

This talk by professor Mona Bafadhel focuses on Eosinophilis in COPD as a major healthcare burden and cause of mortality worldwide.

• COPD as a major healthcare burden and cause of mortality worldwide
• Exacerbations are a hallmark of COPD
• Damage from exacerbations goes beyond the lungs
• Biology-led approaches in COPD
• Eosinophilic and non-eosinophilic COPD: Blood
• COPD and Asthma
• Monoclonal antibodies in eosinophilic COPD?

Mona Bafadhel holds the positions of Chair in Respiratory Medicine at King’s College London and Director of the recently established King’s Centre for Lung Health. Additionally, she works as a consultant respiratory physician at the Guy’s and St. Thomas’ NHS Foundation Trust. Her areas of interest in both clinical and research are asthma and chronic obstructive pulmonary disease (COPD). With a strong desire to use clinical research to better patient outcomes, Mona is a leading international academic in the field of respiratory medicine. Her research on COVID-19 and COPD has changed therapeutic practices that impact millions of people worldwide. The Royal College of Physicians bestowed to Mona the Goulstonian Lectureship in 2018 in recognition of her achievements in the clinical sciences. She is the first woman from an ethnic minority and just the fourth overall.